Annual Operating Profit
-$143.16 M
-$80.45 M-128.28%
December 31, 2023
Summary
- As of February 7, 2025, TARS annual operating income is -$143.16 million, with the most recent change of -$80.45 million (-128.28%) on December 31, 2023.
- During the last 3 years, TARS annual operating profit has fallen by -$116.16 million (-430.25%).
- TARS annual operating profit is now -10504.30% below its all-time high of -$1.35 million, reached on December 31, 2018.
Performance
TARS Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$25.16 M
+$8.14 M+24.44%
September 30, 2024
Summary
- As of February 7, 2025, TARS quarterly operating income is -$25.16 million, with the most recent change of +$8.14 million (+24.44%) on September 30, 2024.
- Over the past year, TARS quarterly operating profit has increased by +$19.29 million (+43.39%).
- TARS quarterly operating profit is now -334.85% below its all-time high of $10.71 million, reached on March 31, 2021.
Performance
TARS Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$140.60 M
+$15.77 M+10.09%
September 30, 2024
Summary
- As of February 7, 2025, TARS TTM operating income is -$140.60 million, with the most recent change of +$15.77 million (+10.09%) on September 30, 2024.
- Over the past year, TARS TTM operating profit has increased by +$2.56 million (+1.79%).
- TARS TTM operating profit is now -22111.37% below its all-time high of -$633.00 thousand, reached on September 30, 2019.
Performance
TARS TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
TARS Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -128.3% | +43.4% | +1.8% |
| 3 y3 years | -430.3% | +43.4% | +1.8% |
| 5 y5 years | -10000.0% | +43.4% | +1.8% |
TARS Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1077.6% | at low | -381.7% | +43.4% | -1056.5% | +10.1% |
| 5 y | 5-year | -3230.8% | at low | -334.9% | +43.4% | -8088.6% | +10.1% |
| alltime | all time | <-9999.0% | at low | -334.9% | +43.4% | <-9999.0% | +10.1% |
Tarsus Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$25.16 M(-24.4%) | -$140.60 M(-10.1%) |
| Jun 2024 | - | -$33.30 M(-11.6%) | -$156.37 M(+0.3%) |
| Mar 2024 | - | -$37.68 M(-15.2%) | -$155.89 M(+8.9%) |
| Dec 2023 | -$143.16 M(+128.3%) | -$44.45 M(+8.6%) | -$143.16 M(+25.8%) |
| Sep 2023 | - | -$40.94 M(+24.7%) | -$113.77 M(+18.8%) |
| Jun 2023 | - | -$32.82 M(+31.5%) | -$95.74 M(+40.5%) |
| Mar 2023 | - | -$24.95 M(+65.7%) | -$68.14 M(+8.7%) |
| Dec 2022 | -$62.71 M(+415.9%) | -$15.06 M(-34.2%) | -$62.71 M(+1.0%) |
| Sep 2022 | - | -$22.91 M(+338.5%) | -$62.10 M(+13.1%) |
| Jun 2022 | - | -$5.22 M(-73.2%) | -$54.90 M(+29.5%) |
| Mar 2022 | - | -$19.52 M(+35.1%) | -$42.39 M(+248.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$12.16 M(-55.0%) | -$14.45 M(-8.0%) | -$12.16 M(+32.3%) |
| Sep 2021 | - | -$15.71 M(-315.7%) | -$9.19 M(+153.6%) |
| Jun 2021 | - | $7.28 M(-32.0%) | -$3.62 M(-74.4%) |
| Mar 2021 | - | $10.71 M(-193.4%) | -$14.17 M(-47.5%) |
| Dec 2020 | -$27.00 M(+528.2%) | -$11.48 M(+13.2%) | -$27.00 M(+62.6%) |
| Sep 2020 | - | -$10.14 M(+210.8%) | -$16.61 M(+134.0%) |
| Jun 2020 | - | -$3.26 M(+54.1%) | -$7.10 M(+85.1%) |
| Mar 2020 | - | -$2.12 M(+95.4%) | -$3.83 M(+123.4%) |
| Dec 2019 | -$4.30 M(+218.4%) | -$1.08 M(+71.2%) | -$1.72 M(+171.2%) |
| Sep 2019 | - | -$633.00 K | -$633.00 K |
| Dec 2018 | -$1.35 M | - | - |
FAQ
- What is Tarsus Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual operating profit year-on-year change?
- What is Tarsus Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly operating profit year-on-year change?
- What is Tarsus Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals TTM operating profit year-on-year change?
What is Tarsus Pharmaceuticals annual operating income?
The current annual operating profit of TARS is -$143.16 M
What is the all time high annual operating profit for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual operating income is -$1.35 M
What is Tarsus Pharmaceuticals annual operating profit year-on-year change?
Over the past year, TARS annual operating income has changed by -$80.45 M (-128.28%)
What is Tarsus Pharmaceuticals quarterly operating income?
The current quarterly operating profit of TARS is -$25.16 M
What is the all time high quarterly operating profit for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly operating income is $10.71 M
What is Tarsus Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, TARS quarterly operating income has changed by +$19.29 M (+43.39%)
What is Tarsus Pharmaceuticals TTM operating income?
The current TTM operating profit of TARS is -$140.60 M
What is the all time high TTM operating profit for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high TTM operating income is -$633.00 K
What is Tarsus Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, TARS TTM operating income has changed by +$2.56 M (+1.79%)